BCAAs were the gold standard. Then the research caught up.

For over a decade, branched-chain amino acids — leucine, isoleucine, and valine — dominated the sports nutrition market. The logic seemed airtight: leucine is the primary activator of muscle protein synthesis, BCAAs are oxidized during exercise, and they’re found in high concentrations in muscle tissue.

The problem is that the science moved on, and BCAAs didn’t.

What BCAAs actually do — and what they don’t

BCAAs do activate the mTOR signaling pathway that initiates protein synthesis. Leucine in particular is a potent trigger. This is not in dispute.

What the research of the last decade has clarified is whether activating that signal translates into actual muscle building when you’re only providing 3 of the 9 essential amino acids. The answer, repeatedly and consistently, is no.

A rigorous 2017 review by Wolfe in the Journal of the International Society of Sports Nutrition examined the totality of BCAA evidence and concluded that BCAAs alone cannot promote muscle protein synthesis or produce an anabolic response in human subjects. The reasoning is straightforward: to build complete muscle proteins, you need all 9 EAAs. Providing only 3 is like delivering bricks to a construction site with no lumber, wiring, or plumbing.

Wolfe’s analysis showed that BCAAs, taken in isolation, may actually decrease muscle protein synthesis. The mechanism: BCAA supplementation activates the synthetic machinery, which then pulls the remaining 6 EAAs from existing muscle protein. You break down muscle to build muscle. Net result: negative or zero.

The head-to-head evidence

Jackman et al. (2017) showed in Frontiers in Physiology that 5.6g of BCAAs after resistance exercise stimulated myofibrillar MPS 22% more than placebo — but this was approximately 50% less than the response seen with an equivalent dose of whey protein containing all EAAs, as measured by Witard et al. (2014) using the same tracer methodology.

Fuchs et al. (2019) compared 6g of BCAAs to 30g of milk protein in healthy older males and found that while BCAAs transiently stimulated MPS in the first 2 hours, the response was not sustained — unlike the complete protein, which maintained elevated synthesis through 5 hours. The conclusion: BCAAs activate the machinery but can’t sustain it without the full complement of amino acids.

A comprehensive 2023 update by Jackman et al. in Nutrition Research Reviews confirmed that while BCAA can transiently stimulate MPS rates, the effect is consistently less than that observed following ingestion of a complete protein source.

The pattern is unambiguous: you need the full team, not just the stars.

Why BCAAs are still everywhere

If the science is this clear, why are BCAAs still one of the best-selling supplement categories?

Marketing momentum. Billions of dollars in brand equity don’t reverse overnight.

The leucine narrative. Leucine’s role as the mTOR trigger is real and makes compelling copy. What gets left out is that triggering a signal is not the same as completing a process.

Price. BCAAs are cheaper to manufacture than complete EAA blends.

None of these are scientific reasons. They’re market reasons.

What the shift to EAAs actually means for you

You get the signal AND the substrate. Full-spectrum EAAs activate mTOR while providing all nine building blocks needed to actually synthesize new muscle protein.

You stop robbing Peter to pay Paul. With BCAAs alone, your body catabolizes existing muscle to source the missing 6 EAAs. With a complete formula, net protein balance stays positive.

You get more per gram. A smaller total dose of EAAs produces greater protein synthesis than a larger dose of BCAAs. You’re paying for amino acids that actually get utilized.

Recovery improves. All 9 EAAs support not just MPS but also immune function, connective tissue repair, neurotransmitter production (tryptophan → serotonin), and other recovery processes BCAAs can’t address.

BCAAs aren’t useless — they’re just incomplete

BCAAs aren’t harmful at reasonable doses. There’s some evidence they can reduce perceived exertion during endurance exercise and may modestly reduce muscle soreness. But every benefit attributed to BCAAs is delivered more effectively by a complete EAA formula that includes the BCAAs plus the six additional amino acids needed to follow through on the anabolic signal.

References

1. Wolfe RR. Branched-chain amino acids and muscle protein synthesis in humans: myth or reality? J Int Soc Sports Nutr. 2017;14:30. PubMed
2. Jackman SR, Witard OC, Philp A, et al. Branched-chain amino acid ingestion stimulates muscle myofibrillar protein synthesis following resistance exercise in humans. Front Physiol. 2017;8:390. PubMed
3. Witard OC, Jackman SR, Breen L, et al. Myofibrillar muscle protein synthesis rates subsequent to a meal in response to increasing doses of whey protein at rest and after resistance exercise. Am J Clin Nutr. 2014;99(1):86-95. PubMed
4. Fuchs CJ, Hermans WJH, Holwerda AM, et al. Branched-chain amino acid and branched-chain ketoacid ingestion increases muscle protein synthesis rates in vivo in older adults. Clin Nutr. 2019;38(5):2066-2075. PubMed
5. Jackman SR, Witard OC, Jackman SR, et al. The effects of branched-chain amino acids on muscle protein synthesis, muscle protein breakdown and associated molecular signalling responses in humans: an update. Nutr Res Rev. 2023;36(2):1-16. PubMed
6. Santos CS, Nascimento FEL. Isolated branched-chain amino acid intake and muscle protein synthesis in humans: a biochemical review. Einstein (São Paulo). 2019;17(3):eRB4898. PMC